Structure and expression of two porcine genomic clones encoding class I MHC antigens.

PubWeight™: 1.32‹?› | Rank: Top 10%

🔗 View Article (PMID 2991383)

Published in J Immunol on September 01, 1985

Authors

M L Satz, L C Wang, D S Singer, S Rudikoff

Articles citing this

Ribonuclease H activities associated with viral reverse transcriptases are endonucleases. Proc Natl Acad Sci U S A (1989) 1.67

A molecular map of the chicken major histocompatibility complex: the class II beta genes are closely linked to the class I genes and the nucleolar organizer. EMBO J (1988) 1.44

Identification of negative and positive regulatory elements associated with a class I major histocompatibility complex gene. Mol Cell Biol (1988) 1.33

Class I genes and molecules: an update. Immunology (1986) 1.05

Contrasting roles of interallelic recombination at the HLA-A and HLA-B loci. Genetics (1993) 1.03

Alternative processing of H-2Dd pre-mRNAs results in membrane expression of differentially phosphorylated protein products. EMBO J (1986) 0.95

Genetic polymorphism of the swine major histocompatibility complex ( SLA) class I genes, SLA-1, -2 and -3. Immunogenetics (2003) 0.83

Identification and DNA sequence of an interspersed repetitive DNA element in the genome of the miniature swine. Nucleic Acids Res (1987) 0.83

Structure, function, and evolution of mouse TL genes, nonclassical class I genes of the major histocompatibility complex. Proc Natl Acad Sci U S A (1994) 0.82

A novel type of retinoic acid response element in the second intron of the mouse H2Kb gene is activated by the RAR/RXR heterodimer. Nucleic Acids Res (1996) 0.78

Rapid assignment of swine leukocyte antigen haplotypes in pedigreed herds using a polymerase chain reaction-based assay. Immunogenetics (2003) 0.76

Preparation and characterization of murine monoclonal antibodies to swine lymphocyte antigens. Immunology (1988) 0.75

Articles by these authors

Molecular cloning and expression of cDNAs for the human interleukin-2 receptor. Nature (1984) 7.37

Immune system impairment and hepatic fibrosis in mice lacking the dioxin-binding Ah receptor. Science (1995) 6.03

Purification and characterization of a newly identified growth factor specific for epithelial cells. Proc Natl Acad Sci U S A (1989) 5.10

The three-dimensional structure of a phosphorylcholine-binding mouse immunoglobulin Fab and the nature of the antigen binding site. Proc Natl Acad Sci U S A (1974) 3.92

Genetics of a new IgVH (T15 idiotype) marker in the mouse regulating natural antibody to phosphorylcholine. J Exp Med (1974) 3.64

Aryl-hydrocarbon receptor-deficient mice are resistant to 2,3,7,8-tetrachlorodibenzo-p-dioxin-induced toxicity. Toxicol Appl Pharmacol (1996) 3.01

The two-component, ATP-dependent Clp protease of Escherichia coli. Purification, cloning, and mutational analysis of the ATP-binding component. J Biol Chem (1988) 2.95

Sequence and structure of Clp P, the proteolytic component of the ATP-dependent Clp protease of Escherichia coli. J Biol Chem (1990) 2.71

Purification and molecular cloning of a secreted, Frizzled-related antagonist of Wnt action. Proc Natl Acad Sci U S A (1997) 2.36

GFRalpha1 is an essential receptor component for GDNF in the developing nervous system and kidney. Neuron (1998) 2.34

NITROGEN FIXATION BY CELL-FREE PREPARATIONS FROM MICROORGANISMS. Proc Natl Acad Sci U S A (1960) 2.28

Different molecular events result in low protein levels of mannan-binding lectin in populations from southeast Africa and South America. J Immunol (1998) 2.11

VH genes encoding the immune response to beta-(1,6)-galactan: somatic mutation in IgM molecules. EMBO J (1984) 1.98

Arrangement of a highly repeated DNA sequence in the genome and chromatin of the African green monkey. J Biol Chem (1979) 1.97

The galactan-binding immunoglobulin Fab J539: an X-ray diffraction study at 2.6-A resolution. Proteins (1986) 1.96

Two-amino acid molecular switch in an epithelial morphogen that regulates binding to two distinct receptors. Science (2000) 1.95

Immunoglobulin structure: amino terminal sequences of mouse myeloma proteins that bind phosphorylcholine. Science (1974) 1.94

Classification of mouse VK groups based on the partial amino acid sequence to the first invariant tryptophan: impact of 14 new sequences from IgG myeloma proteins. Mol Immunol (1982) 1.93

Structural evidence for independent joining region gene in immunoglobulin heavy chains from anti-galactan myeloma proteins and its potential role in generating diversity in complementarity-determining regions. Proc Natl Acad Sci U S A (1979) 1.89

An active v-abl protein tyrosine kinase blocks immunoglobulin light-chain gene rearrangement. Genes Dev (1994) 1.85

Monoclonal antibodies to DNA and RNA from NZB/NZW F1 mice: antigenic specificities and NH2 terminal amino acid sequences. J Immunol (1984) 1.69

Repression of MHC class I gene promoter activity by two-exon Tat of HIV. Science (1993) 1.68

Structural basis for the specificity of phosphorylcholine-binding immunoglobulins. Immunochemistry (1976) 1.63

Nucleic acid and protein sequences of phosphocholine-binding light chains. J Exp Med (1981) 1.61

Structure at 4.5 A resolution of a phosphorylcholine-binding fab. Nat New Biol (1973) 1.60

Somatic diversification of immunoglobulins. Proc Natl Acad Sci U S A (1984) 1.59

Appropriateness of medication selection for older persons in an urban academic emergency department. Acad Emerg Med (1999) 1.58

Purification and NH2-terminal sequence of a plasmacytoma growth factor derived from the murine macrophage cell line P388D1. J Immunol (1987) 1.55

Interleukin 6 is essential for in vivo development of B lineage neoplasms. J Exp Med (1995) 1.49

Activation of target-tissue immune-recognition molecules by double-stranded polynucleotides. Proc Natl Acad Sci U S A (1999) 1.48

Single amino acid substitution altering antigen-binding specificity. Proc Natl Acad Sci U S A (1982) 1.46

Signalling by the RET receptor tyrosine kinase and its role in the development of the mammalian enteric nervous system. Development (1999) 1.46

Spectral changes on binding of oligosaccharides to murine immunoglobulin A myeloma proteins. Biochemistry (1973) 1.45

Berry phase in a composite system. Phys Rev Lett (2004) 1.44

In vivo induction of IL-6 by administration of exogenous cytokines and detection of de novo serum levels of IL-6 in tumor-bearing mice. J Immunol (1989) 1.41

Somatic mutation in a cultured mouse myeloma cell affects antigen binding. Proc Natl Acad Sci U S A (1982) 1.39

Interleukin-2-mediated modulation of plasma cell tumor growth in a model of multiple myeloma. Hum Gene Ther (1998) 1.39

Structural requirements for the binding of derivatives of D-galactose to two homogeneous murine immunoglobulins. Biochemistry (1974) 1.38

HIV-1 tat binds TAFII250 and represses TAFII250-dependent transcription of major histocompatibility class I genes. Proc Natl Acad Sci U S A (1998) 1.36

Crystals of phosphorylcholine-binding Fab-fragments from mouse myeloma proteins: preparation and x-ray analysis. Proc Natl Acad Sci U S A (1972) 1.34

Persephin, a novel neurotrophic factor related to GDNF and neurturin. Neuron (1998) 1.34

Identification of negative and positive regulatory elements associated with a class I major histocompatibility complex gene. Mol Cell Biol (1988) 1.33

Variable region sequence of the heavy chain from a phosphorylcholine binding myeloma protein. Biochemistry (1974) 1.31

Galactan-binding antibodies. Diversity and structure of idiotypes. J Exp Med (1983) 1.30

Size differences among immunoglobulin heavy chains from phosphorylcholine-binding proteins. Proc Natl Acad Sci U S A (1976) 1.27

A diastereoselective metal-catalyzed [2+2] cycloaddition of bis-enomes. J Am Chem Soc (2001) 1.27

The uptake inhibitors cocaine and benztropine differentially alter the conformation of the human dopamine transporter. J Biol Chem (2001) 1.26

Novel post-translational regulation of TCR expression in CD4+CD8+ thymocytes influenced by CD4. Nature (1990) 1.24

Polymorphism in immunoglobulin heavy chains suggesting gene conversion. Proc Natl Acad Sci U S A (1982) 1.24

Purification and properties of Gal repressor:pL-galR fusion in pKC31 plasmid vector. J Biol Chem (1987) 1.23

A spontaneously arising mutation in the DLAARN motif of murine ZAP-70 abrogates kinase activity and arrests thymocyte development. Immunity (1997) 1.22

Six BALB-c IgA myeloma proteins that bind beta-(1-6)-D-galactan. Partial amino acid sequences and idiotypes. J Exp Med (1973) 1.22

Polymorphism in anti-phosphocholine antibodies reflecting evolution of immunoglobulin families. J Exp Med (1983) 1.21

T cell derived IL-6 is differentially required for antigen-specific antibody secretion by primary and secondary B cells. J Immunol (1989) 1.20

Transcriptional coactivator, CIITA, is an acetyltransferase that bypasses a promoter requirement for TAF(II)250. Mol Cell (2001) 1.20

Noncovalently bonded subunits of 22 and 28 kd are rapidly internalized by T cells reacted with anti-Leu-4 antibody. J Immunol (1983) 1.19

Studies on the interaction of H1 histone with superhelical DNA: characterization of the recognition and binding regions of H1 histones. Nucleic Acids Res (1976) 1.19

Central role for differential gene expression in mammalian hibernation. Proc Natl Acad Sci U S A (1992) 1.19

Retinal axon divergence in the optic chiasm: dynamics of growth cone behavior at the midline. J Neurosci (1994) 1.19

Insulin-like growth factor I is a dual effector of multiple myeloma cell growth. Blood (2000) 1.17

k Chain variable regions from three galactan binding myeloma proteins. Biochemistry (1978) 1.17

Neurturin exerts potent actions on survival and function of midbrain dopaminergic neurons. J Neurosci (1998) 1.15

TAFII55 binding to TAFII250 inhibits its acetyltransferase activity. Proc Natl Acad Sci U S A (2001) 1.15

Long-term effects of fertilization on soil organic carbon changes in continuous corn of northeast China: RothC model simulations. Environ Manage (2003) 1.14

kappa Chain joining segments and structural diversity of antibody combining sites. Proc Natl Acad Sci U S A (1980) 1.13

A role for interleukin-6 in parathyroid hormone-induced bone resorption in vivo. Endocrinology (1999) 1.13

Resistance of MHC class I-deficient mice to experimental systemic lupus erythematosus. Science (1993) 1.13

Immunoglobulin structure--function correlates: antigen binding and idiotypes. Contemp Top Mol Immunol (1983) 1.12

Autoregulation of thyroid-specific gene transcription by thyroglobulin. Proc Natl Acad Sci U S A (1998) 1.12

Expression of a microinjected porcine class I major histocompatibility complex gene in transgenic mice. Science (1985) 1.12

Characterization of a porcine genomic clone encoding a major histocompatibility antigen: expression in mouse L cells. Proc Natl Acad Sci U S A (1982) 1.12

Diastereoselective cobalt-catalyzed aldol and Michael cycloreductions. J Am Chem Soc (2001) 1.11

A complex regulatory DNA element associated with a major histocompatibility complex class I gene consists of both a silencer and an enhancer. Mol Cell Biol (1991) 1.10

H5 Histone and DNA-relaxing enzyme of chicken erythrocytes. Interaction with superhelical DNA. J Biol Chem (1976) 1.09

kappa Chain variable region from M167, a phosphorylcholine binding myeloma protein. Biochemistry (1978) 1.07

Sequence variation among heavy chains from inulin-binding myeloma proteins. Proc Natl Acad Sci U S A (1978) 1.06

Relationships between B cell and myeloid differentiation. Studies with a B lymphocyte progenitor line, HAFTL-1. J Exp Med (1988) 1.05

Evidence for gene conversion among immunoglobulin heavy chain variable region genes. J Exp Med (1984) 1.05

In vitro culture of primary plasmacytomas requires stromal cell feeder layers. Proc Natl Acad Sci U S A (1993) 1.05

Functional antibody lacking a variable-region disulfide bridge. Proc Natl Acad Sci U S A (1986) 1.04

Genetic basis for expression of the idiotypic network. One unique Ig VH germline gene accounts for the major family of Ab1 and Ab3 (Ab1') antibodies of the GAT system. J Exp Med (1986) 1.04

T cells induce terminal differentiation of transformed B cells to mature plasma cell tumors. Proc Natl Acad Sci U S A (1995) 1.04

Growth cone form is behavior-specific and, consequently, position-specific along the retinal axon pathway. J Neurosci (1997) 1.03

Association of intraocular pressure with the metabolic syndrome and novel cardiometabolic risk factors. Eye (Lond) (2009) 1.03

Inverse correlation between steady-state RNA and cell surface T cell receptor levels. FASEB J (1990) 1.02

Physiology of thermoregulation in the pika, Ochotona princeps. Can J Zool (1973) 1.01

Characterization of the developmentally regulated Bacillus subtilis glucose dehydrogenase gene. J Bacteriol (1986) 1.01

Effect of taurine on toxicity of cadmium in rats. Toxicology (2001) 1.00

Allelic forms of the immunoglobulin heavy chain variable region. J Immunol (1980) 1.00

Structural, functional, and idiotypic characteristics of a phosphorylcholine-binding IgA myeloma protein of C57BL/ka allotype. J Exp Med (1975) 0.99

kappa-Chain restriction in anti-galactan antibodies. J Immunol (1982) 0.98

Effect of low temperature on the cytosolic free Ca2+ in rat ventricular myocytes. Cell Calcium (1991) 0.97

TAF(II)250-independent transcription can be conferred on a TAF(II)250-dependent basal promoter by upstream activators. J Biol Chem (2000) 0.97

Behavioral thermoregulation in the pika Ochotona princeps: a field study using radiotelemetry. Can J Zool (1974) 0.96

VL-VH expression by monoclonal antibodies recognizing avian lysozyme. J Immunol (1984) 0.96

Seasonal variations in the rate and capacity of cardiac SR calcium accumulation in a hibernating species. Cryobiology (1991) 0.96

An IgM Waldenström with specificity against phosphorylcholine. Biochemistry (1975) 0.95

Effects of ginsenoside Rb1 on central cholinergic metabolism. Pharmacology (1991) 0.95